Medicina Webinar | Retinal Update 2026
the chair
11th Medicina Webinar
Retinal Update 2026
The diagnosis and management of vitreoretinal diseases is rapidly evolving. Retinal Update 2026 is intended to provide practical insights to clinicians and trainees. The faculty include experts from the US and Europe on diverse topics including uveal melanoma, artificial intelligence, and subretinal hemorrhage.
Uveal melanoma remains the most common primary intraocular malignancy in adults. There is no current consensus on standard treatment of small melanomas. Recent advances in gene expression profiling have the potential to improve clinical outcomes. A practical approach to the care of these patients will be presented.
The rapid development of multimodal artificial intelligence that incorporates multiple data modalities has the potential to improve diagnostic accuracy and assist treatment decisions in patients with vitreoretinal diseases. Many examples will be provided.
Despite recent advances in the care of patients with neovascular age-related macular degeneration, subretinal macular hemorrhage may result in severe vision loss. There is no current consensus on standard treatment of this condition. Various alternatives will be discussed, in terms of clinical outcomes and cost-effectiveness.
We hope that Retinal Update 2026 will provide practical insights that will improve clinical care.
Date: 1 April 2026
Time: 8:00 am EDT
Webinar ID: 867 7550 7735
Webinar Secretariat: journal.webinar@mdpi.com
Meet Our Speakers
Dr. Victor M. Villegas
Department of Ophthalmology, University of Puerto Rico, San Juan, PR 00936, USA;
Victor M. Villegas, MD, is a vitreoretinal surgeon and ocular oncologist and serves as Residency Program Director in the Department of Ophthalmology at the University of Puerto Rico. He holds academic affiliations with the Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, and the Department of Surgery, Ponce Health Sciences University. He is a Past President of the Puerto Rico Society of Ophthalmology and Chair of the Young Ophthalmology Section of the Pan-American Association of Ophthalmology. He is a Guest Editor of the Special Issue “Ophthalmology: New Diagnostic and Treatment Approaches (2nd Edition)”.
Prof. Andrzej Grzybowski
Institute for Research in Ophthalmology, Foundation for Ophthalmology Development, Poznan, Poland;
Prof. Andrzej Grzybowski, M.D., Ph.D., MBA, MAE, EVER, is Professor of Ophthalmology at the University of Warmia and Mazury in Olsztyn and Head of the Institute for Research in Ophthalmology, Foundation for Ophthalmology Development in Poznan. He is Past President of EVER (President 2023-2024), member of the ISRS International Council, Treasurer of the European Academy of Ophthalmology, and founder of the AI in Ophthalmology Society. He is a Guest Editor of the Special Issue “Ophthalmology: New Diagnostic and Treatment Approaches (2nd Edition)”.
Prof. Lyubomyr Lytvynchuk
Department of Ophthalmology, University Hospital Gießen and Marburg, Germany;
Prof. Lyubomyr Lytvynchuk, MD, PhD, is a vitreoretinal surgeon and clinician–scientist specializing in inherited retinal diseases, gene and cell therapy, and pediatric lens and retinal vascular disorders. He studied medicine at Danylo Halytsky Lviv National Medical University and completed his residency and advanced vitreoretinal training at the P.L. Shupyk National Medical Academy in Kyiv, followed by clinical and research fellowships in Vienna, London, Hamburg, and at the Karl Landsteiner Institute for Retinal Research and Imaging. In 2017 he joined the University Hospital Gießen and Marburg, where he has led the Vitreoretinal Service since 2017, and in 2023 he was appointed Head of the Department of Ophthalmology (Gießen campus) and W2 Professor of Translational Retinology at Justus-Liebig University Gießen. He is an active member of multiple national and international scientific societies, including ARVO, ASRS, SOE, EURETINA, EVRS, ESCRS, EVER, DOG and the Retinological Society.
This webinar brought together three international experts on vitreoretinal diseases and surgery to discuss a selection new, controversial topics. The first speaker discussed the early treatment of small uveal melanomas and why some of these lesions should be treated and not observed; the second speaker explored emerging uses of artificial intelligence for the care of patients with retinal diseases; and the third speaker surveyed new surgical techniques for submacular hemorrhages related to various diseases, including neovascular age-related macular degeneration.
The webinar was hosted via Zoom and required registration to attend. The full recording can be found below. In order to learn about future webinars, you can sign up to our newsletter by clicking “Subscribe" at the top of the page.